Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.

PINL:GRPOF - Post by User

Traxion Sab De Cv Ord Shs > News

<< Previous

Bullboard Posts

Next >>

Comment by Pumper4Lifeon Mar 05, 2019 5:19pm

97 Views

Post# 29446289

RE:RE:RE:RE:RE:RE:News

Not even worth debating, it’s two different types of horses. ( it’s like saying gw pharma bet on the wrong horse with epidiolex since it’s all about gel caps)

its actually all about delivery efficacy for the symptomatic root cause.

youngpupper wrote:

Pumper4Life wrote: I thought since you put YEARS in caps, it meant they must’ve had some pretty advanced clinical data (not anecdotal evidence) .. it appears canopy and medreleaf have 2 pending trials, that received no objection letters in mid 2018, doesn’t appear to be YEARS as you put it, it appears MONTHS at best

even Canntrust/apotex have more advanced clinical trials than them

youngpupper wrote:

Pumper4Life wrote: That’s good to know.. where can we find these trials that have been running for years? Couldn’t see it on any official clinical trial site for canopy. Are they in phase 2 or 3 of mice/rat trials?

Ive heard anecdotal trials are highly credible...

youngpupper wrote:

CookeMonster wrote: https://tetrabiopharma.com/investors/press-releases/press-release-details/2019/Tetra-Bio-Pharma-and-Sant-Cannabis-Announce-Completion-of-the-First-Phase-2-Cannabis-Oil-Trial-in-Cancer-and-Non-Cancer-Patients/default.aspx

what a joke lol Medreleaf and Canopy have been running trials like this for YEARS now. Someone needs to take Tetra to court.

It's pretty simple, MedReleaf takes their list of patients and contacts all the ones with a cancer diagnosis and offer them free medical cannabis gel caps and follow up on patient progress.

In terms of Canopy, their only registered trial is for insomnia in adult humans. So their cancer work was likely pilot projects or in collaboration with research institutions (where Canopy provides the medicine but gets a piece of any future IP). See their sponsored research chair at UBC.

TBP and APHA bet on the wrong DIN horse, its going to be gel caps, it was always going to be gel caps. And these trials by MedReleaf and Canopy will prove it.